|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Stanford University |
|---|---|
| Collaborator: |
National Institutes of Health (NIH) |
| Information provided by: | Stanford University |
| ClinicalTrials.gov Identifier: | NCT00568490 |
Purpose
To correlate tumor oxygenation as measured by the Eppendorf electrode with the serum level of secreted proteins known to be induced by tumor hypoxia.
| Condition | Intervention |
|---|---|
|
Head and Neck Cancer Lung Cancer Lip Cancer Lip Neoplasms Head and Neck Cancers |
Procedure: Eppendorf electrode measurements Procedure: Tumor biopsy Procedure: Phlebotomy |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers |
blood, tumor tissue
| Estimated Enrollment: | 600 |
| Study Start Date: | September 1998 |
| Estimated Study Completion Date: | April 2013 |
| Estimated Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |
The endpoints of the study are
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Newly diagnosed patients with head and neck cancer
Inclusion Criteria:Newly diagnosed patients with head and neck cancer who has tumor accessible to tumor oxygenation measurement with a microelectrode.
Contacts and Locations| Contact: Brindhath Bavan | (650) 725-4777 | brindhas@stanford.edu |
| United States, California | |
| Stanford University School of Medicine | Recruiting |
| Stanford, California, United States, 94305 | |
| Contact: Brindhath Bavan 650-725-4777 brindhas@stanford.edu | |
| Contact: Cancer Clinical Trials Office (650) 498-7061 | |
| Principal Investigator: Quynh-Thu Le | |
| Sub-Investigator: Amato Giaccia | |
| Sub-Investigator: Richard L Goode | |
| Sub-Investigator: Harlan Pinto | |
| Sub-Investigator: Dr. Billy W. Loo Jr. M.D. Ph.D. | |
| Principal Investigator: | Quynh-Thu Le | Stanford University |
More Information
| Responsible Party: | Quynh-Thu Le, Stanford University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00568490 History of Changes |
| Obsolete Identifiers: | NCT00185822 |
| Other Study ID Numbers: | SU-11052007-801, 15310; CA67166, 73995, ENT0016 |
| Study First Received: | December 4, 2007 |
| Last Updated: | September 8, 2010 |
| Health Authority: | United States: Food and Drug Administration; United States: Institutional Review Board |
|
Neoplasms Head and Neck Neoplasms Lip Neoplasms Lung Neoplasms Anoxia Neoplasms by Site Mouth Neoplasms Lip Diseases |
Mouth Diseases Stomatognathic Diseases Respiratory Tract Neoplasms Thoracic Neoplasms Lung Diseases Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms |